VentriPoint Diagnostics (CVE:VPT) Stock Price Down 14.7% – What’s Next?

by · The Cerbat Gem

VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) traded down 14.7% during trading on Tuesday . The company traded as low as C$0.15 and last traded at C$0.15. 266,015 shares were traded during trading, a decline of 10% from the average session volume of 294,436 shares. The stock had previously closed at C$0.17.

VentriPoint Diagnostics Trading Down 9.1 %

The company has a market cap of C$24.33 million, a PE ratio of -4.63 and a beta of 0.39. The company has a debt-to-equity ratio of -58.56, a quick ratio of 6.67 and a current ratio of 0.28. The company has a 50 day simple moving average of C$0.11 and a two-hundred day simple moving average of C$0.13.

VentriPoint Diagnostics Company Profile

(Get Free Report)

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.

Featured Stories